JP2022511788A5 - - Google Patents
Info
- Publication number
- JP2022511788A5 JP2022511788A5 JP2021530816A JP2021530816A JP2022511788A5 JP 2022511788 A5 JP2022511788 A5 JP 2022511788A5 JP 2021530816 A JP2021530816 A JP 2021530816A JP 2021530816 A JP2021530816 A JP 2021530816A JP 2022511788 A5 JP2022511788 A5 JP 2022511788A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024195531A JP2025024035A (ja) | 2018-11-30 | 2024-11-08 | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773936P | 2018-11-30 | 2018-11-30 | |
| US62/773,936 | 2018-11-30 | ||
| US201962850464P | 2019-05-20 | 2019-05-20 | |
| US62/850,464 | 2019-05-20 | ||
| PCT/US2019/063413 WO2020112880A1 (en) | 2018-11-30 | 2019-11-26 | Methods of treating conditions related to the s1p1 receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195531A Division JP2025024035A (ja) | 2018-11-30 | 2024-11-08 | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511788A JP2022511788A (ja) | 2022-02-01 |
| JP2022511788A5 true JP2022511788A5 (https=) | 2022-12-05 |
| JPWO2020112880A5 JPWO2020112880A5 (https=) | 2022-12-05 |
Family
ID=68966033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530816A Withdrawn JP2022511788A (ja) | 2018-11-30 | 2019-11-26 | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
| JP2024195531A Pending JP2025024035A (ja) | 2018-11-30 | 2024-11-08 | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195531A Pending JP2025024035A (ja) | 2018-11-30 | 2024-11-08 | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220023258A1 (https=) |
| EP (1) | EP3886841A1 (https=) |
| JP (2) | JP2022511788A (https=) |
| KR (1) | KR102824401B1 (https=) |
| CN (2) | CN118649163A (https=) |
| AU (1) | AU2019387212A1 (https=) |
| CA (1) | CA3120706A1 (https=) |
| IL (1) | IL283414A (https=) |
| WO (1) | WO2020112880A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201906876PA (en) | 2010-01-27 | 2019-09-27 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| MX386419B (es) | 2015-01-06 | 2025-03-18 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
| EP3939965A1 (en) | 2015-06-22 | 2022-01-19 | Arena Pharmaceuticals, Inc. | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders |
| MA47504A (fr) | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
| WO2018151834A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations |
| ES2987794T3 (es) | 2018-06-06 | 2024-11-18 | Arena Pharm Inc | Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA019252B1 (ru) * | 2008-07-23 | 2014-02-28 | Арена Фармасьютикалз, Инк. | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ (1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ, ПРИМЕНИМЫЕ В ЛЕЧЕНИИ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ |
| SG10201906876PA (en) * | 2010-01-27 | 2019-09-27 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| CN106063787A (zh) * | 2012-02-03 | 2016-11-02 | 泰华制药工业有限公司 | 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途 |
| AU2015257589A1 (en) * | 2014-05-09 | 2016-11-24 | Nogra Pharma Limited | Methods for treating inflammatory bowel disease |
| MX386419B (es) * | 2015-01-06 | 2025-03-18 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
| EP3355896A2 (en) * | 2015-09-30 | 2018-08-08 | Nogra Pharma Limited | Methods of using smad7 antisense oligonucleotides based on biomarker expression |
| MA47504A (fr) * | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
-
2019
- 2019-11-26 CA CA3120706A patent/CA3120706A1/en active Pending
- 2019-11-26 AU AU2019387212A patent/AU2019387212A1/en not_active Abandoned
- 2019-11-26 US US17/299,741 patent/US20220023258A1/en not_active Abandoned
- 2019-11-26 CN CN202410692934.XA patent/CN118649163A/zh active Pending
- 2019-11-26 WO PCT/US2019/063413 patent/WO2020112880A1/en not_active Ceased
- 2019-11-26 EP EP19824097.0A patent/EP3886841A1/en active Pending
- 2019-11-26 KR KR1020217019803A patent/KR102824401B1/ko active Active
- 2019-11-26 JP JP2021530816A patent/JP2022511788A/ja not_active Withdrawn
- 2019-11-26 CN CN201980087042.4A patent/CN113226307A/zh active Pending
-
2021
- 2021-05-25 IL IL283414A patent/IL283414A/en unknown
-
2024
- 2024-11-08 JP JP2024195531A patent/JP2025024035A/ja active Pending